VERU INC. (VERU) — research page
US · us-cm-kg/NASDAQ/VERU · as of 2026-11-08
Identity and listing
The issuer is VERU INC., listed on NASDAQ under ticker VERU, with ISIN US92536C2026 and LEI 529900ER63TFLEIJV631. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Wisconsin. Its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | VERU INC. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | VERU | source · 2026-11-08 |
| ISIN | US92536C2026 | source · 2026-11-08 |
| LEI | 529900ER63TFLEIJV631 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Wisconsin | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 43 filings in the twelve months from 2025-11-08 to 2026-11-08, across 16 filing days. The median gap between filing days is 21 days. The latest filing is dated 2026-09-08 and is of type corporate_news, which is 61 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 43 | 21 | 61 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-09-08 | corporate_news | 8-K | 8-K — 8-K (items 8.01,9.01) |
| 2026-08-17 | directors_dealings | 4 | 4 — PRIMARY DOCUMENT |
| 2026-08-10 | results | 10-Q | 10-Q — FORM 10-Q |
| 2026-08-10 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
| 2026-07-02 | corporate_news | 8-K | 8-K — 8-K (items 1.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Cherry Bekaert LLP, located in Atlanta, Georgia. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The record finds two research houses named on the issuer's investor-relations page: Oppenheimer and Canaccord Genuity.
| research house | analyst | source · read date |
|---|---|---|
| Oppenheimer | Leland Gershell | issuer page · 2026-11-11 |
| Canaccord Genuity | Edward Nash | issuer page · 2026-11-11 |
Open research
The record holds no openly published research notes for the issuer. None was found.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0000863894.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/VERU (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/863894/000143774925038089/veru20250930_10k.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://ir.verupharma.com/ (coverage)
- 10.10
- https://mcp.us-cm-kg.ai/record/NASDAQ/VERU (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US92536C2026"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:68b7c908e65e76e8.